Kieger Sustainable Healthcare Fund Class A USD Accumulating

Reference Data

ISIN LU0996778642
Valor Number 58920661
Bloomberg Global ID
Fund Name Kieger Sustainable Healthcare Fund Class A USD Accumulating
Fund Provider Kieger AG Kieger AG
Limmatstrasse 264, CH-8005 Zürich
Phone: +41 44 444 18 44
Web: https://kieger.com/
E-Mail: info@kieger.com
Fund Provider Kieger AG
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager.
Peculiarities

Fund Prices

Current Price * 212.05 USD 10.07.2025
Previous Price * 210.57 USD 09.07.2025
52 Week High * 239.55 USD 30.08.2024
52 Week Low * 198.67 USD 07.04.2025
NAV * 212.05 USD 10.07.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 249,626,966
Unit/Share Assets *** 24,259,380
Trading Information SIX

Performance

YTD Performance +2.20% 31.12.2024
10.07.2025
YTD Performance (in CHF) -10.30% 31.12.2024
10.07.2025
1 month -0.14% 10.06.2025
10.07.2025
3 months +5.00% 10.04.2025
10.07.2025
6 months -0.25% 10.01.2025
10.07.2025
1 year -5.81% 10.07.2024
10.07.2025
2 years +7.84% 10.07.2023
10.07.2025
3 years +13.42% 11.07.2022
10.07.2025
5 years +34.93% 14.07.2020
10.07.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 6.66%
Abbott Laboratories 5.64%
AstraZeneca PLC 5.38%
Novartis AG Registered Shares 5.33%
Roche Holding AG 4.81%
UnitedHealth Group Inc 4.61%
Boston Scientific Corp 3.77%
Vertex Pharmaceuticals Inc 3.66%
Intuitive Surgical Inc 3.42%
Novo Nordisk AS Class B 3.39%
Last data update 30.04.2025

Cost / Risk

TER *** 0.99%
TER date *** 30.09.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.85%
Ongoing Charges *** 0.99%
SRRI ***
SRRI date *** 30.06.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)